The impact of pathogen-reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trial.
Garban, Frederic 1,2; Vilotitch, Antoine 3; Tiberghien, Pierre 4,5; Bosson, Jean Luc 2,3; for the EFFIPAP Study Group
[Miscellaneous] Transfusion Medicine. 32(2):175-177, April 2022.

(Format: HTML, PDF)